Prospective Analysis of Percutaneous Ablations for Cancer Treatment
The efficacy of the percutaneous and transarterial treatments for solid tumors will be
studied. Prospective study on patients who receive percutaneous locoregional therapies,
including radiofrequency ablation (RFA), cryoablation, microwave ablation, IRE and chemical
ablation for treatment of cancer will be performed.
Preoperative clinic chart, procedure note, postoperative chart, pre- and post-operative CT,
MRI or Ultrasound, angiographic findings, biopsy results and pathologic findings, will be
reviewed. Patient survival, treatment responses, complications after the therapy will be
collected from clinic visits and clinical encounters.
Patient overall performance status before and after procedures will be assessed using the
Quality of Life questionnaire (SF-36™ Health Survey).
Time Perspective: Prospective
Effect of percutaneous and transarterial treatments for cancer in quality of life
Patients will complete the QOL questionnare during their follow up visits after procedure. 1 month, 3 months, 6 months and 1 year.
Hyun S Kim, MD
United States: Institutional Review Board
|Emory University Hospital||Atlanta, Georgia 30322|